BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9831389)

  • 1. Optimisation of the conditions for generating human DC initiated antigen specific T lymphocyte lines in vitro.
    Mannering SI; McKenzie JL; Hart DN
    J Immunol Methods; 1998 Oct; 219(1-2):69-83. PubMed ID: 9831389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation of tetanus toxoid to autologous T cells by dendritic cells generated from human blood. Improved specificity with dendritic cells generated without fetal calf serum.
    Büchele S; Höpfl R
    Adv Exp Med Biol; 1997; 417():233-7. PubMed ID: 9286367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing preparation of normal dendritic cells and bcr-abl+ mature dendritic cells derived from immunomagnetically purified CD14+ cells.
    Dietz AB; Bulur PA; Erickson MR; Wettstein PJ; Litzow MR; Wyatt WA; Dewald GW; Tefferi A; Pankratz VS; Vuk-Pavlović S
    J Hematother Stem Cell Res; 2000 Feb; 9(1):95-101. PubMed ID: 10738977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
    Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM
    Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of B70/B7-2 in CD4+ T-cell immune responses induced by dendritic cells.
    Fagnoni FF; Takamizawa M; Godfrey WR; Rivas A; Azuma M; Okumura K; Engleman EG
    Immunology; 1995 Jul; 85(3):467-74. PubMed ID: 7558137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells.
    Hock BD; Starling GC; Daniel PB; Hart DN
    Immunology; 1994 Dec; 83(4):573-81. PubMed ID: 7875738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DR1-restricted bcr-abl (b3a2)-specific CD4+ T lymphocytes respond to dendritic cells pulsed with b3a2 peptide and antigen-presenting cells exposed to b3a2 containing cell lysates.
    Mannering SI; McKenzie JL; Fearnley DB; Hart DN
    Blood; 1997 Jul; 90(1):290-7. PubMed ID: 9207464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-transformed B-cells as efficient antigen presenting cells to propagate Aspergillus-specific cytotoxic T-lymphocytes.
    Ramadan G
    Egypt J Immunol; 2008; 15(1):145-57. PubMed ID: 20306679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukaemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with myelodysplasia: a methodological approach under serum-free culture conditions.
    Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schmid C; Schweiger C; Kolb HJ; Schmetzer HM
    Scand J Immunol; 2005 Jul; 62(1):75-85. PubMed ID: 16091127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single step enrichment of blood dendritic cells by positive immunoselection.
    López JA; Bioley G; Turtle CJ; Pinzón-Charry A; Ho CS; Vuckovic S; Crosbie G; Gilleece M; Jackson DC; Munster D; Hart DN
    J Immunol Methods; 2003 Mar; 274(1-2):47-61. PubMed ID: 12609532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of CMRF-44+ monocyte-derived dendritic cells: insights into phenotype and function.
    Vuckovic S; Fearnley DB; Mannering SI; Dekker J; Whyte LF; Hart DN
    Exp Hematol; 1998 Dec; 26(13):1255-64. PubMed ID: 9845382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell-based assays, but not mannosylation of antigen, improves detection of T-cell responses to proinsulin in type 1 diabetes.
    Narendran P; Elsegood K; Leech NJ; Macindoe WM; Boons GJ; Dayan CM
    Immunology; 2004 Apr; 111(4):422-9. PubMed ID: 15056379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimpanzee dendritic cells with potent immunostimulatory function can be propagated from peripheral blood.
    Barratt-Boyes SM; Henderson RA; Finn OJ
    Immunology; 1996 Apr; 87(4):528-34. PubMed ID: 8675205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia.
    Westermann J; Kopp J; van Lessen A; Hecker AC; Baskaynak G; le Coutre P; Döhner K; Döhner H; Dörken B; Pezzutto A
    Br J Haematol; 2007 May; 137(4):297-306. PubMed ID: 17408402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells that process and present nominal antigens to naive T lymphocytes are derived from CD2+ precursors.
    Takamizawa M; Rivas A; Fagnoni F; Benike C; Kosek J; Hyakawa H; Engleman EG
    J Immunol; 1997 Mar; 158(5):2134-42. PubMed ID: 9036958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priming with dendritic cells can generate strong cytotoxic T cell responses to chronic myelogenous leukemia cells in vitro.
    Syme R; Bryan T; Duggan P; Bajwa R; Stewart D; Glück S
    Stem Cells Dev; 2004 Apr; 13(2):211-21. PubMed ID: 15186738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the immunopotency of Toll-like receptor agonists in an in vitro tissue-engineered immunological model.
    Ma Y; Poisson L; Sanchez-Schmitz G; Pawar S; Qu C; Randolph GJ; Warren WL; Mishkin EM; Higbee RG
    Immunology; 2010 Jul; 130(3):374-87. PubMed ID: 20331478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMRF-44 antibody-mediated depletion of activated human dendridic cells: a potential means for improving allograft survival.
    Koppi T; Munster DJ; Brown L; MacDonald KP; Hart DN
    Transplantation; 2003 May; 75(10):1723-30. PubMed ID: 12777863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.